RIPK1 – or receptor-interacting serine/threonine-protein kinase 1 – is thought to play a role in regulating the immune system, and has been a target for programmes both in inflammatory ...
New research uncovers how a natural polyamine, spermidine, modifies RIPK1 to block inflammation and metabolic damage, opening doors to innovative diabetes treatments. In a recent study published ...
The drugs were designed to target the receptor-interacting serine/threonine-protein kinase 1 (RIPK1) in the TNF receptor pathway associated with inflammation and cell death. The partnership has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback